Thermo Fisher Scientific

TMO · NYSE

$687.37+$7.99 (+1.18%)TodayMarket closed ·
Prev close $679.38

About TMO

Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. The company is headquartered in Waltham, Massachusetts and currently employs 125,000 full-time employees. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offer virtually everything needed for the laboratory. The company also provides purification and filtration technologies.

Employees
125,000
Headquarters
Waltham, Massachusetts
Listed
Aug 27, 1980
Sector
Health Care
Industry
Life Sciences Tools & Services

TMO key statistics

Market cap
251.20B
Price-earnings ratio
36.55
Dividend yield
0.26%
Average volume
2.23M
Volume
2.58M
Open price
$680.17
High today
$693.37
Low today
$679.32
52 Week high
$704.00
52 Week low
$435.27

Thermo Fisher Scientific (TMO) at a glance

As of Oct 20, 2026, Thermo Fisher Scientific (TMO) shares are priced at $687.37, giving the company a market cap of 251.20B, a price-to-earnings ratio of 36.55 and a dividend yield of 0.26%.

Today the stock has traded between $679.32 and $693.37. The current price is 1.2% above the day's low and 0.9% below its high.

Volume so far is 2.58M shares, in line with the average of 2.23M shares a day.

Over the past year Thermo Fisher Scientific has ranged from $435.27 to $704.00, and now sits 94% of the way up that range.

Thermo Fisher Scientific met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $6.03 per share against an estimate of $5.77.

The average analyst price target is $671.18, 2.4% below the current price, from 19 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

79%of 19 analyst ratings say Buy
  • Buy78.9%
  • Hold21.1%
  • Sell0.0%
Price target · 32 analystsAvg $671.18
Low
$559.19
Now
$687.37
High
$819.00

TMO earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 2.7% on average.

  1. Q3 FY24: reported $5.28 per share against an estimate of $5.30
  2. Q4 FY24: reported $6.10 per share against an estimate of $6.00
  3. Q1 FY25: reported $5.15 per share against an estimate of $5.15
  4. Q2 FY25: reported $5.36 per share against an estimate of $5.28
  5. Q3 FY25: reported $5.79 per share against an estimate of $5.55
  6. Q4 FY25: reported $6.57 per share against an estimate of $6.51
  7. Q1 FY26: reported $5.44 per share against an estimate of $5.29
  8. Q2 FY26: reported $6.03 per share against an estimate of $5.77

TMO news

  • Kaustubh Bagalkote

    Meta Platforms, Tesla Could Swing More Than $100 Billion After Earnings

  • Kaustubh Bagalkote

    Lam Research Could Swing $28.6 Billion After Earnings

  • 10 Health Care Stocks With Whale Alerts In Today’s Session

  • Piero Cingari

    The S&P 500 Is Partying at Record Highs: Only 3% of Its Stocks Were Invited

  • Vandana Singh

    EXCLUSIVE: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial

  • Chandrima Sanyal

    JPMorgan’s October Stock Picks Hint at 3 ETF Trades: Value, AI Power, Health Care

  • Press releaseBusiness Wire

    Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026

  • Evette Mitkov

    Thermo Fisher Stock Hits Record High: What's Happening?

Similar companies

Companies in the same industry as Thermo Fisher Scientific

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.